[caption id="attachment_92632" align="aligncenter" width="700"]
Picture for representational purpose[/caption]
Chronic blood cancer Juvenile Myelomonocytic Leukemia (JMML) can now be treated better with stem cell transplant.
According to a new study, researchers have claimed that stem cell transplant can enhance the results of treatment of the rare form of chronic blood cancer and help in its clinical remission.
Researchers have claimed that treating JMMML patients with stem cell transplant have shown improved results.
ALSO READ: Diabetes Drug ‘Actos’ Not Linked To Bladder Cancer Risk, Claims New Study
The study was done by researchers at the Children's Hospital Los Angeles (CHLA), led by Dr Hisham Abdle Azim.
He conducted study on children suffering from JMML disease and underwent cell transplant. It was found that they also showed improved results and clinical remission.
ALSO READ: Unusual ‘Pill On A String’ Can Detect Early Signs Esophageal Cancer
He also said that lack of transplant related mortality among children signals successful cell transplant as chemotherapy.
He also added that conventional dose of chemotherapy before providing cell transplant also help in improving the condition of cancer ridden patient.